Impact of SARS-CoV-2 and Other Upper Respiratory Tract Viral Infections on Reproductive Parameters in Young Healthy Men with Mild Symptoms of Disease

Table 3

Reproductive parameters of SARS-CoV-2 positive men and men with other URTI (SARS-CoV-2 negative) at baseline visit.

	Median (range)		p-Value
	SARS-CoV-2 positive	URTI, but SARS-CoV-2 negative
Sperm concentration (10^6/mL)	36.0 (2.7–68.0)	36.0 (2.4–182.0)	0.89
Morphology (% normal sperm)	4.0 (1.0–6.0)	5.0 (1.0–9.0)	0.30
Total motility, PR + NP (%)	75.0 (53.0–78.0)	75.0 (42.0–86.0)	0.59
Progressive motility, PR (%)	57.0 (43.0–67.0)	55.0 (30.0–86.0)	0.59
Ejaculate volume (mL)	6.1 (2.4–18.3)	3.9 (1.6–6.0)	0.32
DFI (%)	18.0 (8.0–34.0)	9.0 (3.0–22.0)	0.10
HDS (%)	7.0 (2.0–11.0)	9.0 (4.0–17.0)	0.53
FSH (IE/L)	4.2 (3.2–4.9)	5.5 (1.5–6.0)	0.13
LH (IE/L)	6.0 (2.7–13.0)	5.5 (2.8–11.0)	0.84
SHBG (nmol/L)	33.0 (9.0–46.0)	41.0 (15.0–56.0)	0.16
Testosterone (nmol/L)	13.6 (6.0–15.0)	15.0 (10.0–22.0)	0.23
Testosterone/SHBG	0.4 (0.3–0.7)	0.4 (0.2–0.85)	0.95
Free testosterone (nmol/L)	0.2 (0.187–0.387)	0.270 (0.162–0.374)	0.97

Mann–Whitney U test. According to Vermeulen formula.